1. Kutzsche J, Schemmert S, Bujnicki T, Zafiu C, Halbgebauer S, Kraemer-Schulien V, Pils M, Blömeke L, Post J, Kulawik A, Jürgens D, Rossberg WM, Hümpel M, Bannach O, Otto M, Araujo JA, Willuweit A, Willbold D (2023) Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs - A model of sporadic Alzheimer's disease. Heliyon;9: e18443.
2. Pils M, Dybala A, Rehn F, Blömeke L, Bujnicki T, Kraemer-Schulien V, Hoyer W, Riesner D, Willbold D, Bannach O (2023). Development and Implementation of an Internal Quality Control Sample to Standardize Oligomer-Based Diagnostics of Alzheimer's Disease. Diagnostics (Basel);13:
3. Schaffrath A, Schleyken S, Seger A, Jergas H, Özdüzenciler P, Pils M, Blömeke L, Cousin A, Willbold J, Bujnicki T, Bannach O, Fink GR, Willbold D, Sommerauer
M, Barbe MT, Tamgüney G (2023) Patients with isolated REM-sleep behavior disorder have elevated levels of alpha-synuclein aggregates in stool. NPJ Parkinsons Dis;9: 14.
4. Kass B, Schemmert S, Zafiu C, Pils M, Bannach O, Kutzsche J, Bujnicki T, Willbold D (2022) Abeta oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo. Cell Rep Med;3: 100630.
5. Blömeke L, Pils M, Kraemer-Schulien V, Dybala A, Schaffrath A, Kulawik A, Rehn F, Cousin A, Nischwitz V, Willbold J, Zack R, Tropea TF, Bujnicki T, Tamgüney G, Weintraub D, Irwin D, Grossman M, Wolk DA, Trojanowski JQ, Bannach
O, Chen-Plotkin A, Willbold D (2022) Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting. npj Parkinson's Disease;8: 68.
6. Kravchenko K, Kulawik A, Hülsemann M, Kühbach K, Zafiu C, Herrmann Y, Linnartz C, Peters L, Bujnicki T, Willbold J, Bannach O, Willbold D (2017) Analysis of anticoagulants for blood-based quantitation of amyloid beta oligomers in the sFIDA assay. Biological chemistry;398: 465-75.
7. Herrmann Y, Bujnicki T, Zafiu C, Kulawik A, Kühbach K, Peters L, Fabig J, Willbold J, Bannach O, Willbold D (2017) sFIDA automation yields sub-femtomolar limit of detection for Abeta aggregates in body fluids. Clinical biochemistry;50: 244-7.
8. Herrmann Y, Kulawik A, Kühbach K, Hülsemann M, Peters L, Bujnicki T, Kravchenko K, Linnartz C, Willbold J, Zafiu C, Bannach O, Willbold D (2017) Nanoparticle standards for immuno-based quantitation of alpha-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies. Clinica chimica acta; international journal of clinical chemistry;466: 152-9.
